Pharma’s corporate reputation dips among neurology patient groups, citing drug access challenges
3rd November 2025 Uncategorised 0Neurology-focused patient groups’ perception of the pharma industry’s corporate reputation remains on a downward slope.
More: Pharma’s corporate reputation dips among neurology patient groups, citing drug access challenges
Source: fierce
